News ｜ CellFree Sciences

We, CellFree Sciences Co., Ltd. be @ the exhibition of the 72nd Annual Meeting of the Japanese Society for Virology

We, CellFree Sciences Co, Ltd., are pleased to announce that we will be exhibiting at the exhibition of the 72nd Annual Meeting of the Japanese Society for Virology

Dates: October 28 (Tue.) - 30 (Thu.), 2025, 9:00 - 18:40
Venue: ACT CITY Hamamatsu

●Booth No.: 12 
We will introduce the following products and services
 Reagents and kits for Wheat Germ Cell-Free protein synthesis system and contract services

We, CellFree Sciences.Co., Ltd. be @ BioJapan 2025

CellFree Sciences will be at 『BioJapan 2025』 in Yokohama from October 8^th to 10^th.

Dates: October 8 (Wed.) - 10 (Fri.), 2024, 10:00 - 17:00
Venue: Pacifico Yokohama Exhibition Hall
1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan

●Booth No.: A-10 / Ehime University (Protein Island Matsuyama)
We will introduce the following products and services
(1) Reagents and kits for wheat cell-free protein synthesis system and contract services
(2) Molecular interaction analysis service

●Booth No.: B-57 in Yokohama/Kawasaki Pavilion
Cooperative booth with CALICI Co., a U.S. company that provides unique AI based Drug Design platform, "PharmaCo-Net".
We will also introduce our Molecular Interaction Analysis Service using our arrays.
 

 
We look forward to seeing you there and to your registration for online partnering.

We, CellFree Sciences.Co. Ltd. be @ The exhibition of The 63rd Annual Meeting of the Biophysical Society of Japan

CellFree Sciences will be at 『The exhibition of The 63rd Annual Meeting of the Biophysical Society of Japan』 in Nara from Sep. 24^th to 26^th.

• Venue : NARA Prefectural Convention Center

We will introduce the following products and services
"Reagents and kits for wheat cell-free protein synthesis system and contract services"
And at this exhibition, we will introduce the platform “PharmaCo-Net®” for Protein structure based AI drug discovery by CALICI.

We sincerely look forward to seeing you at our booth No42.

CellFree Sciences Co., Ltd.

The final day of 3rd Targeted Protein Degradation Conference in Japan』 has started

 『3rd Targeted Protein Degradation Conference in Japan』

The final day of the conference has started.

Welcome to our booth.

Day 2 yesterday, our staff introduced “MaZiQ array technology” at the Partner Presentation.

.
CellFree Sciences Co., Ltd.
Sales & Marketing Division

We, CellFree Sciences.Co., Ltd. be @ 3rd Targeted Protein Degradation Conference in Japan

 CellFree Sciences will be at 『3rd Targeted Protein Degradation Conference in Japan』 from July 29^th to 31^st.^.

 Dates: July 29^th (Tue.) - 31^st (Thu.), 2025, 9:00 - 17:00

Venue: Shonan iPark, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, Japan

•  We will introduce the services by MaZiQ array^Ⓡ for TPD Drug Discovery.

We, CellFree Sciences.Co., Ltd. be @ The 25th Annual Meeting of the Protein Science Society of Japan

CellFree Sciences will be at 『The 25th Annual Meeting of the Protein Science Society of Japan』 in Himeji from June 18^th to 20^th.

Dates: June 18^th (Wed.) - 20^th (Fri.), 2025, 9:00 - 17:00
Venue: Arcrea HIMEJI 143-2 Kamiyacho, Himeji City, Hyogo Prefecture 670-0836

●Booth No. 22
We will introduce the following products and services
"Reagents and kits for wheat cell-free protein synthesis system and contract services"
"Molecular interaction analysis service with MaZiQ array^®”

CellFree Sciences, MOU Signed With CALICI

CellFree Sciences-CALICI, Innovative Drug Development - Treatment Research MOU Signed

Accelerating Synergy in Innovative Drug Development between Korea and Japan

CALICI, a protein structure-based AI drug discovery (SBDD) company headquartered in the US and Korea, and CellFree Sciences (CFS), a Japanese company based in Yokohama known for its wheat germ cell-free protein expression technology and MaZiQ array^TM system (an array of unmodified human genomic protein beads), recently signed an agreement and formalized their partnership.

This partnership aims to make breakthrough progress in the development of treatments for infectious diseases, metabolic disorders, and cancer through in silico and experimental protein interaction research, target validation/off-target analysis, and mechanism of action research by combining CALICI's expertise in AI modeling and drug candidate optimization with CFS's services for analyzing intermolecular interactions and proteomics profiling.

The two companies will act as mutual agencies for each other's services in Korea and Japan, and will promote cross-border collaboration and provide smooth customer access to innovative technologies. The two companies also began a non-public joint research.

“CFS's MaZiQ array® will validate the results of AI-designed drug candidates and add meaning to experimental success, and through this, our partnership will be able to provide new drug development companies with higher value-added services,” said CFS CEO Ozawa Satoshi.

Dr. Jae Moon Choi, CEO of CALICI, said, “This partnership symbolizes a new era of drug development, and aims to create synergies by combining the unique technologies of both companies to develop more efficient new drugs and treatments for diseases.” He added, “I expect that the two companies will be able to provide breakthrough solutions to both countries faster and more efficiently together.”

Meanwhile, CALICI was selected as the 6th Daejeon company for IBK Changgo, an innovative startup company development program run by IBK.

We, CellFree Sciences.Co., Ltd. be @ 20th The Korean Society of Nonclinical Study

We are joining  the exhibition of   『20th The Korean Society of Nonclinical Study Worshop』 in Gyeongju of Korea.

Dates: October 17th (The) - 18th  (Fri.), 2024, 10:00 - 17:00
Venue: LAHAN Select Hotel in  Gyeongju  .

We Join this exhibition for the aim of customer acquisition of collaboration between CALICI Co which  which has an advanced platform (Pharmaco-Net) that combines AI-based compound design with the calculation of K_D values, and we, CellFree Sciences, which supplies the assay service  by MaZiQ arrayTM  for TPD drug discovery, Protac, transcription factors and so on.

We, CellFree Sciences.Co., Ltd. be @ BioJapan 2024

CellFree Sciences will be at 『BioJapan 2024』 in Yokohama from October 9^th to 11^th.

Dates: October 9 (Wed.) - 11 (Fri.), 2024, 10:00 - 17:00
Venue: Pacifico Yokohama Exhibition Hall
1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan

●Booth No.: A-36 / Ehime University (Protein Island Matsuyama)
We will introduce the following products and services
(1) Reagents and kits for wheat cell-free protein synthesis system and contract services
(2) Molecular interaction analysis service
●Booth No.: B-25 in Yokohama/Kawasaki Pavilion
Cooperative booth with CALICI Co., a U.S. company that provides unique AI based Drug Design service.
We will also introduce our Molecular Interaction Analysis Service using our arrays.
 
We also plan to hold a seminar on 10/10(Thu.).
Time: 11:30-12:00 
Place: Presentation Stage B
Speaker: Professor Tatsuya Sawasaki, Center for Proteoscience, Ehime University
Lecture Title: “Proximity-dependent biotin labeling of interacting proteins using AirID
 
We look forward to seeing you there and to your registration for online partnering.

Revised manual for "ProteoLiposome BD Kit" was uploaded.

Revised manual for "ProteoLiposome BD Kit" was uploaded , now.

The content of the method for Rehydration of lyophilized Liposomes has been revised.

CellFree Sciences Co., Ltd.